
MicroProtein Technologies is the first company to produce recombinant biologics on an industrial scale without employing the conventional fermentation process.
Our facilities and CMO services are now cGMP certified.
Latest News October 2021: MicroProtein Technologies now offers product Human IL-2 October 2021: MicroProtein Technologies now offers product Streptavidin May 2021: MicroProtein Receives ISO 9001:2015 GMP Certification April 2018: J. Schroeder Joins MicroProtein Technologies as Director of Quality April 2018: S.R. Rangineni, M.D., has Joined MicroProtein as Vice President of Business Development and Strategy